SHAPING THE FUTURE OF SINGLE VENTRICLE HEART DISEASE (SVHD) Trademark

Trademark Overview


On Thursday, November 8, 2018, a trademark application was filed for SHAPING THE FUTURE OF SINGLE VENTRICLE HEART DISEASE (SVHD) with the United States Patent and Trademark Office. The USPTO has given the SHAPING THE FUTURE OF SINGLE VENTRICLE HEART DISEASE (SVHD) trademark a serial number of 88186670. The federal status of this trademark filing is REGISTERED as of Tuesday, May 4, 2021. This trademark is owned by Mezzion Pharma Co., Ltd.. The SHAPING THE FUTURE OF SINGLE VENTRICLE HEART DISEASE (SVHD) trademark is filed in the Education & Entertainment Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Educational services, namely, seminars in the field of pharmaceuticals, medicine, health, wellbeing, and cardiac issues and distribution of course materials in connection therewith; providing a website featuring blogs in the field of pharmaceuticals, medicine, health, wellbeing, and cardiac issues

Providing websites featuring information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals and medicine, health, wellness, and cardiac health issues; Medical testing and screening services, namely, medical diagnostic testing services and medical screening for the treatment of cardiac disease and disorders, and single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation; providing a website featuring information in the field of health and wellness; providing a website featuring medical information in the field of cardiac issues; medical testing services, namely, providing medical testing services and information in the field of the treatment of cardiac disease and disorders

Medical and pharmaceutical research for the treatment of cardiac disease and disorders; Medical and pharmaceutical research for the treatment of cardiac disease and disorders, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation and product development services; scientific and technological research services related thereto, namely, scientific research services for the treatment of cardiac disease and disorders, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation; Medical and pharmaceutical research for the treatment of cardiac disease and disorders, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation; conducting clinical trials for others
shaping the future of single ventricle heart disease (svhd)

General Information


Serial Number88186670
Word MarkSHAPING THE FUTURE OF SINGLE VENTRICLE HEART DISEASE (SVHD)
Filing DateThursday, November 8, 2018
Status700 - REGISTERED
Status DateTuesday, May 4, 2021
Registration Number6337606
Registration DateTuesday, May 4, 2021
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 16, 2021

Trademark Statements


Goods and ServicesEducational services, namely, seminars in the field of pharmaceuticals, medicine, health, wellbeing, and cardiac issues and distribution of course materials in connection therewith; providing a website featuring blogs in the field of pharmaceuticals, medicine, health, wellbeing, and cardiac issues
Goods and ServicesProviding websites featuring information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals and medicine, health, wellness, and cardiac health issues; Medical testing and screening services, namely, medical diagnostic testing services and medical screening for the treatment of cardiac disease and disorders, and single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation; providing a website featuring information in the field of health and wellness; providing a website featuring medical information in the field of cardiac issues; medical testing services, namely, providing medical testing services and information in the field of the treatment of cardiac disease and disorders
Goods and ServicesMedical and pharmaceutical research for the treatment of cardiac disease and disorders; Medical and pharmaceutical research for the treatment of cardiac disease and disorders, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation and product development services; scientific and technological research services related thereto, namely, scientific research services for the treatment of cardiac disease and disorders, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation; Medical and pharmaceutical research for the treatment of cardiac disease and disorders, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation; conducting clinical trials for others

Classification Information


International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateTuesday, November 27, 2018
Primary Code041
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, November 27, 2018
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, July 31, 2019
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMezzion Pharma Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressSeoul 06163
KR

Party NameMezzion Pharma Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressSeoul 06167
KR

Party NameMezzion Pharma Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSeoul 06167
KR

Trademark Events


Event DateEvent Description
Tuesday, January 22, 2019ASSIGNED TO EXAMINER
Monday, November 12, 2018NEW APPLICATION ENTERED
Tuesday, November 27, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, July 24, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, January 24, 2019NON-FINAL ACTION WRITTEN
Thursday, January 24, 2019NON-FINAL ACTION E-MAILED
Thursday, January 24, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, July 29, 2019ASSIGNED TO LIE
Wednesday, July 31, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 31, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, August 2, 2019SUSPENSION LETTER WRITTEN
Friday, August 2, 2019LETTER OF SUSPENSION E-MAILED
Friday, August 2, 2019NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, February 10, 2020SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Monday, February 10, 2020SUSPENSION INQUIRY WRITTEN
Monday, February 10, 2020INQUIRY TO SUSPENSION E-MAILED
Monday, February 10, 2020NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Thursday, June 25, 2020TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, July 1, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 1, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 2, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, July 2, 2020NON-FINAL ACTION WRITTEN
Thursday, July 2, 2020NON-FINAL ACTION E-MAILED
Tuesday, December 29, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, December 30, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, December 29, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, January 4, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, January 8, 2021ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Tuesday, February 16, 2021PUBLISHED FOR OPPOSITION
Tuesday, February 16, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, January 27, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 4, 2021REGISTERED-PRINCIPAL REGISTER
Wednesday, May 29, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, May 29, 2024TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, May 29, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, May 29, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, May 29, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, May 29, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, August 23, 2024TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Friday, August 23, 2024TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Friday, August 23, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, August 23, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, August 23, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED